Search Results - "Miraglio, Emanuela"

Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy by Lo Nigro, Cristiana, Ricci, Vincenzo, Vivenza, Daniela, Granetto, Cristina, Fabozzi, Teresa, Miraglio, Emanuela, Merlano, Marco C

“…AIM: To reviewing genetic and epigenetic make-up of metastatic colorectal cancers(m CRCs) addicted to epidermal growth factor receptor(EGFR)…”
Get full text

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer by Marmorino, Federica, Salvatore, Lisa, Barbara, Cecilia, Allegrini, Giacomo, Antonuzzo, Lorenzo, Masi, Gianluca, Loupakis, Fotios, Borelli, Beatrice, Chiara, Silvana, Banzi, Maria Chiara, Miraglio, Emanuela, Amoroso, Domenico, Dargenio, Francesco, Bonetti, Andrea, Martignetti, Angelo, Paris, Myriam, Tomcikova, Daniela, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara

“…Background: Different antiangiogenics are currently indicated in the second-line treatment of metastatic colorectal cancer (mCRC), following a first-line…”
Get full text

Eribulin in advanced breast cancer: safety, efficacy and new perspectives by Garrone, Ornella, Miraglio, Emanuela, Vandone, Anna Maria, Vanella, Paola, Lingua, Daniele, Merlano, Marco C

“…Eribulin is a synthetic analog of halichondrin B belonging to microtubule-targeted agents with a distinct mechanism of inhibition of microtubule dynamics. This…”
Get full text

Predictive role of clinical benefit (CB) at 1st line on the outcome of subsequent lines in metastatic breast cancer (MBC) patients: analysis of a “real life” population by Garrone, Ornella, Di Maio, Massimo, Vandone, Anna Maria, Brizio, Rodolfo, Vanella, Paola, Miraglio, Emanuela, Comino, Alberto, Merlano, Marco Carlo

“…Abstract only…”
Get full text

Nab-paclitaxel in clinical practice: Preliminary data from the mantel study by Garrone, Ornella, Saggia, Chiara, Bergnolo, Paola, Beano, Alessandra, Castiglione, Federico, Vanella, Paola, Turletti, Anna, De Conciliis, Enrico, Vellani, Giorgio, Denaro, Nerina, Bellini, Elisa, Miraglio, Emanuela, Merlano, Marco Carlo

“…Abstract only e12561 Background: Metastatic breast cancer (MBC) is an incurable disease. The main goals of treatment are palliation, symptoms control,…”
Get full text

Lactate dehydrogenase (LDH) levels to predict benefit from the continuation of bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Subgroup analysis of the randomized BEBYP study by Marmorino, Federica, Cremolini, Chiara, Loupakis, Fotios, Barbara, Cecilia, Dargenio, Francesco, Miraglio, Emanuela, Masi, Gianluca, Salvatore, Lisa, Marcucci, Lorenzo, Antonuzzo, Lorenzo, Chiara, Silvana, Banzi, Chiara, Schirripa, Marta, Amoroso, Domenico, Bonetti, Andrea, Martignetti, Angelo, Paris, Myriam, Boni, Luca, Tomcikova, Daniela, Falcone, Alfredo

“…Abstract only…”
Get full text

Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients by Lo Nigro, Cristiana, Ricci, Vincenzo, Vivenza, Daniela, Monteverde, Martino, Strola, Giuliana, Lucio, Francesco, Tonissi, Federica, Miraglio, Emanuela, Granetto, Cristina, Fortunato, Mirella, Merlano, Marco Carlo

“…To investigate the prognostic role of invariant natural killer T (iNKT) cells and antibody-dependent cell-mediated cytotoxicity (ADCC) in wild type KRAS…”
Get full text

T memory cells in the tumor invasive margins affect survival in colon cancer (CC) but not in breast cancer (BC) by Merlano, Marco Carlo, Ricci, Vincenzo, Garrone, Ornella, Ferrero, Martina, Vivenza, Daniela, Granetto, Cristina, Miraglio, Emanuela, Cauchi, Carolina, Denaro, Nerina, Occelli, Marcella, Fea, Elena, Vandone, Anna Maria, Vanella, Paola, Di Costanzo, Gianna, Colantonio, Ida, Varamo, Chiara, Lattanzio, Laura, Lo Nigro, Cristiana, Comino, Alberto

“…Abstract only…”
Get full text

Phase II randomized study of induction FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in metastatic colorectal cancer (mCRC): The MOMA trial by Salvatore, Lisa, Loupakis, Fotios, Cremolini, Chiara, Masi, Gianluca, Bergamo, Francesca, Galiano, Antonella, Zagonel, Vittorina, Ferrari, Laura, Ongaro, Elena, Cardellino, Giovanni, Marcucci, Lorenzo, Lucchesi, Sara, Banzi, Maria, Ciarlo, Andrea, Miraglio, Emanuela, Delfanti, Sara, Corsi, Domenico C., Zaniboni, Alberto, Tonini, Giuseppe, Falcone, Alfredo

“…Abstract only…”
Get full text

Antibody-dependent cell-mediated cytotoxicity (ADCC) evolution under treatment by cetuximab and links with treatment outcome in colorectal cancer (CRC) patients by Merlano, Marco Carlo, Monteverde, Martino, Strola, Giuliana, Barriere, Jerome, Etienne-Grimaldi, Marie-Christine, Miraglio, Emanuela, Lattanzio, Laura, Vivenza, Daniela, Messa, Francesca, Lo Nigro, Cristiana, Milano, Gerard A.

“…Abstract only 2600 Background: ADCC plays a role in antitumor activity of IgG1 mAb by inducing immune cell-mediated lysis of tumor cells. We evaluated ADCC…”
Get full text

Second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) who progressed to a first-line treatment containing BV: Updated results of the phase III “BEBYP” trial by the Gruppo Oncologico Nord Ovest (GONO) by Masi, Gianluca, Loupakis, Fotios, Salvatore, Lisa, Cremolini, Chiara, Fornaro, Lorenzo, Schirripa, Marta, Granetto, Cristina, Miraglio, Emanuela, Di Costanzo, Francesco, Antonuzzo, Lorenzo, Marcucci, Lorenzo, Barbara, Cecilia, Boni, Corrado, Banzi, Maria, Chiara, Silvana, Garbarino, Daniela, Valsuani, Chiara, Bonetti, Andrea, Boni, Luca, Falcone, Alfredo

“…Abstract only 3615 Background: Retrospective data suggested that the continuation of BV with second-line CT beyond progression (PD) in pts who received BV in…”
Get full text

Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Receiving a First-Line Treatment Containing Bevacizumab: Update of Bebyp Trial by Gono by Salvatore, Lisa, Masi, Gianluca, Loupakis, Fotios, Cremolini, Chiara, Schirripa, Marta, Fornaro, Lorenzo, Granetto, Cristina, Miraglio, Emanuela, Di Costanzo, Francesco, Antonuzzo, Lorenzo, Marcucci, Lorenzo, Cupini, Samanta, Boni, Corrado, Banzi, Maria, Chiara, Silvana, Garbarino, Daniela, Valsuani, Chiara, Bonetti, Andrea, Boni, Luca, Falcone, Alfredo

Get full text

A prospective randomised study of transvaginal ultrasound effects of tamoxifen and exemestane in postmenopausal women with early breast cancer by Garrone, Ornella, Bertelli, Gianfilippo, Principe, Ernesto, Lewis, Paul D, Occelli, Marcella, Miraglio, Emanuela, Merlano, Marco C

“…A reduction of gynaecological adverse events has been reported in trials comparing aromatase inhibitors with tamoxifen as adjuvant treatment in postmenopausal…”
Get full text